Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut microbiome-dependent IL-1 signaling is a mediator of ACVR1R206H-driven heterotopic ossification. | bioRxiv | 2026 | 41993555 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva: A Case Report From the UAE. | Cureus | 2026 | 41970064 | PubTator, text mining | PubMed |
| [Fibrodysplasia ossificans progressive: a clinicopathological and molecular genetic analysis of three cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41956746 | PubTator, text mining | PubMed |
| A pharmacological profile of pacritinib for the treatment of myelofibrosis. | Expert Rev Clin Pharmacol | 2026 | 41949314 | PubTator, text mining | PubMed |
| Mitotic error correction and the spindle assembly checkpoint: a tension-filled relationship. | Cell Cycle | 2026 | 41930946 | PubTator, text mining | PubMed |
| Integrated transcriptome-proteome analysis in patients with myelofibrosis-related anemia. | Ann Hematol | 2026 | 41902926 | PubTator, text mining | PubMed |
| Prevalence and Clinicoradiopathological Characterization of H3 K27-Altered Diffuse Midline Gliomas in Adults-A Retrospective Observational Study. | Pathophysiology | 2026 | 41893372 | PubTator, text mining | PubMed |
| Age and Maturation Stage Linked Consequences of Fibrinogen on Human Oligodendroglia. | J Neurosci Res | 2026 | 41866764 | PubTator, text mining | PubMed |
| Comparison of two-stage methods for count data in Mendelian randomization: a simulation study. | J Comp Eff Res | 2026 | 41847956 | PubTator, text mining | PubMed |
| Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. | Curr Hematol Malig Rep | 2026 | 41793580 | PubTator, text mining | PubMed |
| The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes. | Curr Hematol Malig Rep | 2026 | 41790379 | PubTator, text mining | PubMed |
| Spinal cord injury-induced overflow incontinence reshapes the activin-follistatin-inhibin axis in mouse bladder and kidney. | Front Mol Biosci | 2026 | 41788624 | PubTator, text mining | PubMed |
| Genetics and pathophysiology of diffuse idiopathic skeletal hyperostosis. | Front Endocrinol (Lausanne) | 2026 | 41782748 | PubTator, text mining | PubMed |
| Computational analysis of hub genes associated with sarcopenia: integrative transcriptome insights from an Asian cohort. | EXCLI J | 2026 | 41768858 | PubTator, text mining | PubMed |
| Activin A secretion by muscle-repairing macrophages induces heterotopic ossification in mice. | J Clin Invest | 2026 | 41766667 | PubTator, text mining | PubMed |
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. | J Clin Med | 2026 | 41753113 | PubTator, text mining | PubMed |
| Recent Advances in Anti-Mullerian Hormone (AMH)-Related Osteoporosis Research. | Biomedicines | 2026 | 41751326 | PubTator, text mining | PubMed |
| Expression Analysis of miRNA Profiles in Colorectal Cancer with a Bioinformatics Approach: An Emphasis on miR-4295, miR-4720-5p, miR-4773, and miR-6831-5p. | Diagnostics (Basel) | 2026 | 41750762 | PubTator, text mining | PubMed |
| Optogenetics for Investigating and Targeting Hallmark Traits of Cancer. | Biomolecules | 2026 | 41750287 | PubTator, text mining | PubMed |
| Differential causes of masticatory muscle disorders in dogs: a review of diagnosis, treatment and long-term management. | Front Vet Sci | 2026 | 41743561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=2